13 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
Surgi Max Ultra
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Paltop
FDA UDI
PALTOP ADVANCED DENTAL SOLUTIONS LTD·07290108691108·Titanium Angulated Multi-Unit Abutment Int. Hex...
Millennium
FDA UDI
Avalign Technologies, Inc.·00190776369224·Van Buren Catheter Guide
ONE TOUCH PROFILE
FDA Adverse Event
Malfunction
·LIFESCAN, INC.·Product code CFR·November 19, 2001
SMITH & NEPHEW SURESHOT DISTAL TARGETING SYSTEM V2.0
FDA 510(k)
FDA Class 2
·Neurology
PARI HYDRATE G
FDA 510(k)
FDA Class 2
·Anesthesiology
MYKNEE STD FEMUR DISTAL PIN POSITIONER - MRI - GMK - RIGHT - #6
FDA Adverse Event
Malfunction
·MEDACTA INTERNATIONAL SA·Product code JWH·March 14, 2018
Widex
FDA UDI
Widex A/S·05706069897845·WIDEX EVOKE E-XP (Dark brown ) 30, Telecoil, RC...
MYKNEE STD FEMUR DISTAL PIN POSITIONER - MRI - GMK SPHERE- LEFT - SIZE6+
FDA Adverse Event
Malfunction
·MEDACTA INTERNATIONAL SA·Product code JWH·March 14, 2018
840 VENTILATOR
FDA Adverse Event
Malfunction
·COVIDIEN·Product code CBK·October 14, 2014
TENSION FREE VAGINAL TAPE
FDA Adverse Event
Injury
·ETHICON, INC.·Product code PAH·June 14, 2013
CAPIOX RX OXYGENATOR W/HS RESERVOIR
FDA Adverse Event
Other
·TERUMO CARDIOVASCULAR SYSTEMS CORP.·Product code DTZ·June 20, 2011
Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.
FDA Enforcement
Class II
·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020